Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/24073
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBermel, R.-
dc.contributor.authorComi, G.-
dc.contributor.authorEralinna, J. -P.-
dc.contributor.authorLeist, T. P.-
dc.contributor.authorNicholas, R.-
dc.contributor.authorOreja-Guevara, C.-
dc.contributor.authorSiva, A.-
dc.contributor.authorVAN WIJMEERSCH, Bart-
dc.contributor.authorWiendl, H.-
dc.contributor.authorBernasconi, C.-
dc.contributor.authorBuffels, R.-
dc.contributor.authorCsoboth, C.-
dc.contributor.authorHan, J.-
dc.contributor.authorMusch, B.-
dc.contributor.authorVermersch, P.-
dc.date.accessioned2017-08-04T12:24:40Z-
dc.date.available2017-08-04T12:24:40Z-
dc.date.issued2016-
dc.identifier.citationMULTIPLE SCLEROSIS JOURNAL, 22, p. 615-616 (Art N° P1180)-
dc.identifier.issn1352-4585-
dc.identifier.urihttp://hdl.handle.net/1942/24073-
dc.description.sponsorshipSponsored by F. Hoffmann-La Roche Ltd.-
dc.language.isoen-
dc.publisherSAGE PUBLICATIONS LTD-
dc.titleDesign of two phase III open-label trials evaluating ocrelizumab in patients with relapsing-remitting multiple sclerosis and suboptimal response to disease-modifying treatment-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateSEP 14-17, 2016-
local.bibliographicCitation.conferencename32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-
local.bibliographicCitation.conferenceplaceLondon, ENGLAND-
dc.identifier.epage616-
dc.identifier.spage615-
dc.identifier.volume22-
local.format.pages2-
local.bibliographicCitation.jcatM-
dc.description.notes[Bermel, R.] Cleveland Clin, Mellen Ctr MS, Cleveland, OH 44106 USA. [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy. [Eralinna, J. -P.] NEO Res, Turku, Finland. [Leist, T. P.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA. [Nicholas, R.] Imperial Coll Healthcare NHS Trust, London, England. [Nicholas, R.] Imperial Coll, London, England. [Oreja-Guevara, C.] Hosp Clin San Carlos, Madrid, Spain. [Siva, A.] Istanbul Univ, Cerrahpasa Sch Med, Cerrahpasa, Turkey. [Van Wijmeersch, B.] Univ Hasselt, Hasselt, Belgium. [Van Wijmeersch, B.] Rehabil & MS Ctr Overpelt, Hasselt, Belgium. [Wiendl, H.] Univ Munster, Munster, Germany. [Bernasconi, C.; Buffels, R.] F Hoffmann La Roche Ltd, Basel, Switzerland. [Csoboth, C.; Han, J.; Musch, B.] Genentech Inc, San Francisco, CA 94080 USA. [Vermersch, P.] Ctr Hosp Reg Univ Lille, Lille, France.-
local.publisher.placeLONDON-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
local.bibliographicCitation.artnrP1180-
dc.identifier.isi000383267202379-
dc.identifier.urlhttps://onlinelibrary.ectrims-congress.eu/ectrims/2016/32nd/145863/robert.bermel.design.of.two.phase.iii.open-label.trials.evaluating.ocrelizumab.html?f=p6m3e1031o14005-
item.fulltextWith Fulltext-
item.contributorBermel, R.-
item.contributorComi, G.-
item.contributorEralinna, J. -P.-
item.contributorLeist, T. P.-
item.contributorNicholas, R.-
item.contributorOreja-Guevara, C.-
item.contributorSiva, A.-
item.contributorVAN WIJMEERSCH, Bart-
item.contributorWiendl, H.-
item.contributorBernasconi, C.-
item.contributorBuffels, R.-
item.contributorCsoboth, C.-
item.contributorHan, J.-
item.contributorMusch, B.-
item.contributorVermersch, P.-
item.fullcitationBermel, R.; Comi, G.; Eralinna, J. -P.; Leist, T. P.; Nicholas, R.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Bernasconi, C.; Buffels, R.; Csoboth, C.; Han, J.; Musch, B. & Vermersch, P. (2016) Design of two phase III open-label trials evaluating ocrelizumab in patients with relapsing-remitting multiple sclerosis and suboptimal response to disease-modifying treatment. In: MULTIPLE SCLEROSIS JOURNAL, 22, p. 615-616 (Art N° P1180).-
item.accessRightsOpen Access-
crisitem.journal.issn1352-4585-
crisitem.journal.eissn1477-0970-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Abstract.pdfPeer-reviewed author version261.39 kBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.